Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 6

Safety-net facilities and hospitalization rates of chronic obstructive pulmonary disease: a cross-sectional analysis of the 2007 Texas Health Care Information Council inpatient data

Authors Jackson BE, Suzuki S, Coultas D, Su F, Lingineni R, Singh KP, Bartolucci A, Bae S

Published 11 November 2011 Volume 2011:6 Pages 563—571

DOI https://dx.doi.org/10.2147/COPD.S26072

Review by Single-blind

Peer reviewer comments 4

Bradford E Jackson1, Sumihiro Suzuki1, David Coultas2, Fenghsiu Su1,3, Ravi Lingineni1, Karan P Singh1, Alfred Bartolucci4, Sejong Bae1
1Department of Biostatistics, University of North Texas Health Science Center School of Public Health, Fort Worth, TX, 2Department of Medicine, University of Texas Health Science Center at Tyler, Tyler, TX, 3Center for Learning and Development, University of North Texas Health Science Center, Fort Worth, TX, 4Department of Biostatistics, University of Alabama at Birmingham School of Public Health, Birmingham, AL, USA

Purpose: Geographic disparities in hospitalization rates for chronic obstructive pulmonary disease (COPD) have been observed in Texas. However, little is known about the sources of these variations. The purpose of this manuscript is to further explore the geographic disparity of COPD hospitalization rates in Texas by examining county-level factors affecting access to care.
Patients and methods: The study is a cross-sectional analysis of the 2007 Texas Health Care Information Council, Texas, demographer population projections and the 2009 Area Resource File (ARF). The unit of analysis was county-specific hospitalization rate, calculated as the number of discharges of county residents divided by county-level population estimates. Indicators of access to care included: type of safety-net facility and number of pulmonary specialists in a county. Safety-net facilities of interest were federally qualified health centers (FQHCs) and rural health clinics (RHCs).
Results: There was a significant difference (P < 0.05) in hospitalization rates according to health center presence. Counties with only FQHCs had the lowest COPD hospitalization rate (132 per 100,000 observations), and counties with only RHCs had the highest hospitalization rate (229 per 100,000 observations). The presence of a pulmonary specialist was associated with a significant decrease (25%) in hospitalization rates among counties with only FQHCs.
Conclusion: In Texas, counties with only FQHCs were associated with lower COPD hospitalization rates. The presence of a RHC alone may be insufficient to decrease hospitalizations from COPD. There are a number of factors that may contribute to these variations in hospitalization rates, such as racial/ethnic distribution, types and quality of services provided, and the level of rurality, which creates greater distances to care and lower concentration of hospitals and pulmonary specialists.

Keywords: health centers, COPD, health disparities

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Effect of surface roughness on osteogenesis in vitro and osseointegration in vivo of carbon fiber-reinforced polyetheretherketone–nanohydroxyapatite composite

Deng Y, Liu X, Xu A, Wang L, Luo Z, Zheng Y, Deng F, Wei J, Tang Z, Wei S

International Journal of Nanomedicine 2015, 10:1425-1447

Published Date: 17 February 2015

The mediating role of cytokine IL-6 on the relationship of FEV1 upon 6-minute walk distance in chronic obstructive pulmonary disease

Baldi S, Jose PE, Bruschi C, Pinna GD, Maestri R, Rezzani A, Bellinzona E, Fracchia C, Dacosto E, Crotti P, Montemartini S

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:1091-1099

Published Date: 7 October 2014

The importance of knowing the home conditions of patients receiving long-term oxygen therapy

Godoy I, Tanni SE, Hernández C, Godoy I

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:421-425

Published Date: 5 July 2012

Spirometric testing on World COPD Day

Tanja Grzetic-Romcevic, Boris Devcic, Silvana Sonc,

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:141-146

Published Date: 10 February 2011

Prevalence and risk factors for unrecognized obstructive lung disease among urban drug users

M Bradley Drummond, Gregory D Kirk, Jacquie Astemborski, et al

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:89-95

Published Date: 19 January 2011

Candesartan cilexetil in the treatment of chronic heart failure

Jean-Philippe Baguet, Gilles Barone-Rochette, Yannick Neuder

Vascular Health and Risk Management 2009, 5:257-264

Published Date: 4 March 2009